Recently formed medical device maker Claret Medical, Inc. raised $3.38 million in a Series A private equity offering.
The Santa Rosa, Calif.-based company raised $3.38 million out of the $3.5 million sought, according to an SEC report.
Claret also landed a CE Mark for its Montage system to protect against brain embolism during vascular surgery. Montage is the first filtration system to protect both carotid arteries simultaneously.
The catheter is delivered during intravascular procedures such as transcatheter aortic valve intervention and can remove potentially stroke causing embolic material from the body.
"The CE Mark approval for the Montage System is an exciting new step forward to potentially reduce stroke rates in TAVI and other vascular procedures," Eberhard Grube, director of the Structural Heart Program at University Hospital in Bonn, Germany, said in prepared remarks.
Here’s a roundup of other dealflow and investment news:
- Echo announces warrant exercise by largest shareholder
Echo Therapeutics (NSDQ: ECTE) announced a warrant exercise for the price os $1.7 million by its largest shareholder, Platinum Partners.
- Tangent Medical closes $4.5M in Series A
Tangent Medical Technologies, Inc.
closed $4.5 million in series A equity financing co-led by Arboretum Ventures and Flagship Ventures.
- Mx Orthopedics steps up to $1M
Mx Othopedica Corp. has taken $1 million in seed financing round, according to an SEC report filed by the company.
- North Carolina Innovation Fund to invest in life science companies
A North Carolina Innovation Fund to invest $35M from the state’s pension fund in early-stage life science companies.
- PhysioSonics lands $2.5M from U.S. Army
PhysioSonics landed a $2.5 million grant from the Telemedicine and Advanced Technology Research Center to optimize its cerebral blood-flow monitor to detect vasospasm.